Literature DB >> 27423624

Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis.

Hiroki Masuda1, Masahiro Mori2, Akiyuki Uzawa1, Mayumi Muto1, Tomohiko Uchida1, Ryohei Ohtani1, Ryutaro Akiba3, Hirotaka Yokouchi3, Shuichi Yamamoto3, Satoshi Kuwabara1.   

Abstract

BACKGROUND: Both neuromyelitis optica spectrum disorder (NMOsd) and multiple sclerosis (MS) patients experience optic neuritis (ON) attacks characterized by rapidly reduced best-correct visual acuity (BCVA) and slow recovery. Prognosis and effects of recurrence on recovery may differ between disorders but remain unclear.
OBJECTIVE: To compare ON severity, time and degree of recovery and effects of previous ON between NMOsd and MS patients.
METHODS: Retrospective chart review was performed. BCVA measurements acquired before ON, at nadir and during recovery were retrospectively reviewed. Records were obtained on 69 ON attacks in 36 NMOsd patients and 43 attacks in 28 MS patients, including first episodes and recurrences.
RESULTS: NMOsd patients exhibited significantly lower BCVA values at all time points after attack (P<0.05), reached nadir earlier (P=0.014) and regained a smaller fraction of baseline BCVA than MS patients (P<0.001). In NMOsd, relapsed ON resulted in worse recovery and tended to reach nadir earlier than first-episode ON (P=0.030 and 0.059, respectively). In MS, relapsed ON also reached nadir earlier (P=0.042); however, there was no difference in recovery.
CONCLUSIONS: Recovery from ON was poorer in NMOsd than in MS and was negatively affected by previous ON attacks.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-aquaporin-4 antibodies; Multiple sclerosis; Neuromyelitis optica spectrum disorder; Optic neuritis; Prognosis; Visual acuity

Mesh:

Year:  2016        PMID: 27423624     DOI: 10.1016/j.jns.2016.06.036

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.

Authors:  Sidney M Gospe; John J Chen; M Tariq Bhatti
Journal:  Eye (Lond)       Date:  2020-12-15       Impact factor: 3.775

2.  Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.

Authors:  Marinos G Sotiropoulos; Hrishikesh Lokhande; Brian C Healy; Mariann Polgar-Turcsanyi; Bonnie I Glanz; Rohit Bakshi; Howard L Weiner; Tanuja Chitnis
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-05-28

3.  Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study.

Authors:  Jian Yu; Yongheng Huang; Lei Zhou; Jingzi ZhangBao; Yuan Zong; Chao Quan; Min Wang
Journal:  J Neurol       Date:  2021-06-04       Impact factor: 6.682

4.  Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis.

Authors:  Jindapa Srikajon; Sasitorn Siritho; Chanon Ngamsombat; Naraporn Prayoonwiwat; Niphon Chirapapaisan
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-08-11

5.  Comparing evolvement of visual field defect in neuromyelitis optica spectrum disorder-optic neuritis and idiopathic optic neuritis: a prospective study.

Authors:  Jiaqi Liang; Yuxin Zhang; Kaiqun Liu; Xiaoyu Xu; Xiujuan Zhao; Wei Qiu; Xinyu Zhang; Hui Yang
Journal:  BMC Ophthalmol       Date:  2022-08-09       Impact factor: 2.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.